Hassan Hussain Almasoudi

13PUBLICATIONS
42CO-AUTHORS
Molecular targetsBiologically active moleculesNanomedicineBiomolecular modelling and designSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Feb 16, 2026
Retraction Note: Alternative use of Droxidopa for treating cervical cancer: inhibiting transferase, cell cycle signalling, and transport proteins via multitarget docking, DFT, MD simulations, and binding free energy studies.

Saleh Hussain A Almasabi, Hassan H Almasoudi, Hassan Albargy

|Jul 07, 2025
Targeting dysregulated molecular pathways in cancer cell lines using small molecule inhibitors as a promising therapeutic strategy.

Hassan H Almasoudi, Shoaib Khan

|Mar 29, 2025
Alternative use of droxidopa for treating cervical cancer: inhibiting transferase, cell cycle signalling, and transport proteins via multitarget docking, DFT, MD simulations, and binding free energy studies.

Saleh Hussain A Almasabi, Hassan H Almasoudi, Hassan Albargy

|Feb 26, 2025
Targeting Plasmodium falciparum Schizont Egress Antigen-1 in Infected Red Blood Cells: Docking-Based Fingerprinting, Density Functional Theory, Molecular Dynamics Simulations, and Binding Free Energy Analysis.

Hassan H Almasoudi, Mohammed H Nahari

|May 02, 2024
Green synthesized silver nanoparticles of Terminalia bellirica leaves extract: synthesis, characterization, in-silico studies, and antimalarial activity.

Sujeet Singh, Hemant Arya, Welka Sahu

|Mar 28, 2024
Structure-based multitargeted docking screening, pharmacokinetics, DFT, and dynamics simulation studies reveal mitoglitazone as a potent inhibitor of cellular survival and stress response proteins of lung cancer.

Abdulkarim S Binshaya, Omar Saad Alkahtani, Fahad M Aldakheel

Pageof 3

Frequent Collaborators

5 joint publications

Mutaib M Mashraqi

3 joint publications

Mohammed H Nahari

2 joint publications

Hassan Albargy

2 joint publications

Abdulfattah Yahya M Alhazmi